Methods previously developed by the author are applied to uncover several sites of interest in the spike glycoproteins of all known human coronaviruses (hCoVs), including SARS-CoV-2 that causes COVID-19. The sites comprise three-dimensional neighborhoods of peptides characterized by four key properties: (1) they pinpoint regions of high free energy in the backbone whose obstruction might interrupt function; (2) by their very definition, they occur rarely in the universe of all gene-encoded proteins that could obviate host response to compounds designed for their interference; (3) they are common to all known hCoV spikes, possibly retaining activity in light of inevitable viral mutation; and (4) they are exposed in the molecular surface of the glycoprotein. These peptides in SARS-CoV-2 are given by the triples of residues (131, 117, 134), (203, 227, 228), and (1058, 730, 731) in its spike.
Get full access to this article
View all access options for this article.
References
1.
AldridgeR.W., LewerD., BealeS., et al.2020. Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (hCoV-NL63, hCoV-OC43, and hCoV-229E): Results from the Flu Watch cohort study. Wellcome Open Res. 5, 52
2.
BelouzardS., ChuV.C., and WhittakerG.R.2009. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl Acad. Sci. U. S. A. 106, 5871–5876.
3.
BermanH.M., WestbrookJ., FengZ., et al.2000. The Protein Data Bank. Nucleic Acids Res. 28, 235–242.
4.
BonaviaA., ZelusB.D., WentworthD.E., et al.2003. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus hCoV-229E. J. Virol. 77, 2530–2538.
5.
BoschB.J., van der ZeeR., de HaanC.A., et al.2003. The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol. 77, 8801–8811.
6.
BurkardC., VerheijeM.H., WichtO., et al.2014. Coronavirus cell entry occurs through the endo/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog. 10, e1004502.
7.
DimmockN.J., EastonA.J., and LeppardK.N.2016. Introduction to Modern Virology, 7th ed. Wiley and Sons, Oxford.
8.
ElenaS.F., and SanjuánR.2005. Adaptive value of high mutation Rates of RNA viruses: Separating causes from consequences. J Virol, 79, 11555–11558.
9.
FinkelsteinA.V., GutinA.M., and Ya BadretdinovA.1995a. Boltzmann-like statistics of protein architectures: Origins and consequences. Subcell Biochem, 24, 1–26.
10.
FinkelsteinA.V., and PtitsynO.2016. Protein Physics, A Course of Lectures, 2nd ed. Academic Press. London.
11.
FinkelsteinA.V., Ya BadretdinovA., and GutinA.M.1995b. Why do protein architectures have Boltzmann-like statistics?. Proteins, 23, 142–150.
12.
GauntE.R., HardieA., ClaasE.C.J., et al. 2010. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 48, 2940–2947.
13.
GuiM., SongW., ZhouH., et al.2017. Cryo-electron microscopy structures of the SARS CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res. 27, 119–129.
14.
HulswitR.J.G, LangY., BakkersM.J.G., et al. 2019. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc. Natl. Acad Sci U. S. A. 116, 2681–2690.
15.
KabschW., and SanderC.1983. DSSP: Definition of secondary structure of proteins given a set of 3D coordinates. Biopolymers, 22, 2577–2637.
16.
KirchdoerferR.N., CottrellC.A., WangN., et al.2016. Pre-fusion structure of a human coronavirus spike protein. Nature, 531, 118–121.
17.
KirchdoerferR.N., WangN., PallesenJ., et al.2018. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci. Rep., 8, 15701.
18.
LevineA.J.1991. Viruses. Scientific American Library, New York.
19.
LiW., MooreM.J., VasilievaN., et al.2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426, 450–454.
20.
LiZ., TomlinsonA.C., WongA.H., et al.2019. The human coronavirus hCoV-229E S-protein structure and receptor binding. eLlife, 8, pii:e51230.
21.
LipsitchM.2020. Who is immune to the coronavirus?. New York Times April, 13, 2020.
22.
MandalS., MoudgilM., and MandalS.K.2009. Rational drug design. Eur. J. Pharmacol. 625, 90–100.
MilletJ.K., and WhittakerG.R.2014. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl Acad. Sci. U. S. A. 111, 15214–15219.
25.
NassarM.S., BakhrebahM.A., MeoS.A., et al.2018. Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS CoV) infection. Eur. Rev. Med. Pharmacol. Sci. 22, 3913–3918.
26.
OuX., Liu,Y., LeiX., et al.2020. Characterization of spike glycoprotein if SARS CoV-2 on virus entry and its immune cross-reactivity with SARS CoV. Nat. Commun. 11, 1620.
27.
PallesenJ., WangN., CorbettK.S., et al.2017. Immunogenicity and structures of a rationally designed prefusipon MERS CoV spike antigen. Proc. Natl Acad. Sci. U. S. A. 114, E7348–E7357.
28.
ParkY.J., WallsA.C., WangZ., et al.2019. Structures of MERS CoV spike glycoprotein in complex with sialoside attachment receptors. Nat. Struct. Mol. Biol. 26, 1151–1157.
29.
PennerR.C.2020. Backbone free energy estimator applied to viral glycoproteins. J. Comput. Biol., 2020 [Epub ahead of print April3, 2020; DOI: 10.1089/cmb.2020.0120].
30.
PennerR.C., AndersenE.S., LedetJ.L., et al. (2014). Hydrogen bond rotations as a uniform structural tool for analyzing protein architecture. Nat. Commun. 5, 5803.
31.
PohlF.M.1971. Empirical protein energy maps. Nat. New Biol. 234, 277–279.
32.
PyrcK., BerkhoutB., and van der HoekL.2007. The Novel Human Coronaviruses NL63 and HKU1. J. Virol. 81, 3051–3057.
33.
RueckertC., and GusmánC.2012. Vaccines: From empirical development to rational design. PLoS Pathog. 8, e1003001.
34.
ShangJ., WanY., LiuC., et al. (2020) Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog. 16, e1008392.
35.
SmithF., WilmA., DineenD., et al.2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol., 7, 539.
36.
SongW., GuiM., WangX., et al.2018. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 14, e1007236.
37.
StröhL.J., and StehleT.2014. Glycan engagement by viruses: Receptor switches and specificity. Annu. Rev. Virol. 285–306.
38.
TorticiM.A., WallsA,C., LangY., et al.2019. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481–489.
39.
VankadariN., and WilceJ.A.2020. Emerging COVID-19 coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg. Microbes Infect. 9, 601–604.
40.
WallsA.C., ParkY.J., TorticiM.A., et al.2020. Structure, function, and antigenicity of the SARS CoV-2 spike glycoprotein. Cell, 181, 281–291.
41.
WallsA.C., TorticiM.A., FrenzB., et al.2016. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 23, 899–905.
42.
WallsA.C., TorticiM.A., SnijderJ., et al.2017. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc. Natl Acad. Sci. U. S. A. 114, 11157–11162.
43.
WallsA.C., TortoriciM.A., XiongX., et al.2019a. Structural studies of coronavirus fusion proteins. Microsc. Microanal. 25, 1300–1301.
44.
WallsA.C., XiongX., ParkY.J., et al.2019b. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell, 176, 1026–1039.
45.
WangH., YangP., LiuK., et al.2008. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocyctic pathway. Cell Res. 18, 290–301.
46.
WangN., RosenO., WangL., et al.2019. Structural definition of a Neutralization-Sensitive Epitope on the MERS CoV S1-NTD. Cell Rep. 28, 3395–3405.
47.
WangN., XuanlingS., JiangL., et al.2013. Structure of MERS CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 23, 986–993.
48.
WesolowskiJ., AlzogarayV., ReyeltJ., et al., 2009. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol. 198, 157–174.
49.
WhiteJ.M., DelosS.E., BrecherM., et al.2008. Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43, 189–219.
50.
WrappD., DeVileger, CorbettK.S., et al.2020. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell, 181, 1–12.
51.
WrappD., and McLellanJ.S.2019. The 3.1-angstrom cryo-electron microscopy structure of the porcine epidemic diarrhea virus spike protein in the prefusion conformation. J. Virol. 93, pii: e00923-19.
52.
WrappD., WangN., CorbettK.S., et al.2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367, 1260–1263.
53.
WuK., LiW., PengG., et al.2009. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc. Natl. Acad. Sci. U. S. A. 106, 19970–19974.
54.
YuanY., CaoD., ZhangY., et al.2017. Cryo-EM structures of MERS CoV and SARS CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun., 8, 15092.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
